Name: Beta Bionics, Inc. (BBNX) Balance Sheet
Creator: FinSpry

Beta Bionics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Beta Bionics, Inc. (BBNX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	30.43	26.57	27.68
Short-Term Investments	73.14	70.18	0.00
Cash & Short-Term Investments	103.58	96.75	27.68
Accounts Receivable	12.00	4.45	0.00
Inventory	13.32	1.25	0.00
Other Current Assets	1.05	0.91	0.54
Total Current Assets	132.92	103.62	28.47
Non-Current Assets
Property, Plant & Equipment (Net)	11.42	6.20	6.87
Other Non-Current Assets	0.25	0.22	0.19
Total Non-Current Assets	16.72	6.42	7.06
Total Assets	149.65	110.04	35.53
Current Liabilities
Accounts Payable	2.85	1.17	0.43
Short-Term Debt	3.06	0.00	0.00
Accrued Liabilities	4.89	7.07	6.14
Deferred Revenue	0.94	0.09	0.00
Other Current Liabilities	0.99	1.05	1.32
Total Current Liabilities	21.15	10.61	8.87
Non-Current Liabilities
Long-Term Debt	5.73	3.00	3.16
Other Non-Current Liabilities	44.90	37.57	10.50
Total Non-Current Liabilities	373.86	302.54	196.69
Total Liabilities	395.01	51.43	22.53
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-296.74	-229.66	-185.57
Accumulated Other Comprehensive Income	0.07	0.14	0.00
Additional Paid-in Capital	51.31	26.42	15.53
Shares Outstanding	42.86	42.86	42.86
Total Stockholders' Equity	-245.36	58.61	13.00
Total Liabilities & Equity	149.65	110.04	35.53